NVCR
Price
$26.17
Change
+$0.15 (+0.58%)
Updated
Jan 17 closing price
Capitalization
1.66B
39 days until earnings call
TRIB
Price
$0.83
Change
+$0.01 (+1.22%)
Updated
Jan 17 closing price
Capitalization
14.9M
Ad is loading...

NVCR vs TRIB

Header iconNVCR vs TRIB Comparison
Open Charts NVCR vs TRIBBanner chart's image
NovoCure
Price$26.17
Change+$0.15 (+0.58%)
Volume$1.18M
Capitalization1.66B
Trinity Biotech
Price$0.83
Change+$0.01 (+1.22%)
Volume$143.33K
Capitalization14.9M
NVCR vs TRIB Comparison Chart
Loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVCR vs. TRIB commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCR is a Hold and TRIB is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (NVCR: $26.17 vs. TRIB: $0.83)
Brand notoriety: NVCR and TRIB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVCR: 87% vs. TRIB: 71%
Market capitalization -- NVCR: $1.66B vs. TRIB: $14.9M
NVCR [@Medical Specialties] is valued at $1.66B. TRIB’s [@Medical Specialties] market capitalization is $14.9M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCR’s FA Score shows that 1 FA rating(s) are green whileTRIB’s FA Score has 1 green FA rating(s).

  • NVCR’s FA Score: 1 green, 4 red.
  • TRIB’s FA Score: 1 green, 4 red.
According to our system of comparison, NVCR is a better buy in the long-term than TRIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCR’s TA Score shows that 3 TA indicator(s) are bullish while TRIB’s TA Score has 2 bullish TA indicator(s).

  • NVCR’s TA Score: 3 bullish, 3 bearish.
  • TRIB’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, NVCR is a better buy in the short-term than TRIB.

Price Growth

NVCR (@Medical Specialties) experienced а -4.66% price change this week, while TRIB (@Medical Specialties) price change was -1.31% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

NVCR is expected to report earnings on May 01, 2025.

TRIB is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than TRIB($14.9M). TRIB YTD gains are higher at: -6.158 vs. NVCR (-12.181). TRIB has higher annual earnings (EBITDA): -26.34M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. TRIB (6.58M). TRIB has less debt than NVCR: TRIB (67.3M) vs NVCR (596M). NVCR has higher revenues than TRIB: NVCR (509M) vs TRIB (71.4M).
NVCRTRIBNVCR / TRIB
Capitalization1.66B14.9M11,134%
EBITDA-177.45M-26.34M674%
Gain YTD-12.181-6.158198%
P/E RatioN/A33.00-
Revenue509M71.4M713%
Total Cash911M6.58M13,849%
Total Debt596M67.3M886%
FUNDAMENTALS RATINGS
NVCR vs TRIB: Fundamental Ratings
NVCR
TRIB
OUTLOOK RATING
1..100
584
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
3965
P/E GROWTH RATING
1..100
819
SEASONALITY SCORE
1..100
853

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRIB's Valuation (57) in the Medical Specialties industry is somewhat better than the same rating for NVCR (100). This means that TRIB’s stock grew somewhat faster than NVCR’s over the last 12 months.

TRIB's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVCR (100). This means that TRIB’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (97) in the Medical Specialties industry is in the same range as TRIB (100). This means that NVCR’s stock grew similarly to TRIB’s over the last 12 months.

NVCR's Price Growth Rating (39) in the Medical Specialties industry is in the same range as TRIB (65). This means that NVCR’s stock grew similarly to TRIB’s over the last 12 months.

NVCR's P/E Growth Rating (8) in the Medical Specialties industry is in the same range as TRIB (19). This means that NVCR’s stock grew similarly to TRIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVCRTRIB
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
79%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bearish Trend 12 days ago
86%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
89%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 28 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
89%
Aroon
ODDS (%)
Bullish Trend 12 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATHM27.651.14
+4.30%
Autohome
AER95.70-0.11
-0.11%
Aercap Holdings NV
DLHC7.92-0.02
-0.25%
DLH Holdings Corp
FIGS5.94-0.18
-2.94%
FIGS
BMRA0.64-0.07
-9.35%
Biomerica

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with FLGT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+0.58%
FLGT - NVCR
41%
Loosely correlated
-2.29%
KIDS - NVCR
39%
Loosely correlated
+2.37%
CTKB - NVCR
36%
Loosely correlated
-0.55%
VCYT - NVCR
35%
Loosely correlated
-1.27%
INMD - NVCR
35%
Loosely correlated
+1.33%
More

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and NVRO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and NVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
+0.67%
NVRO - TRIB
31%
Poorly correlated
+1.56%
RGEN - TRIB
28%
Poorly correlated
-1.44%
NVCR - TRIB
26%
Poorly correlated
+0.58%
SERA - TRIB
23%
Poorly correlated
-2.73%
COO - TRIB
23%
Poorly correlated
+1.34%
More